(Reuters) – Moderna Inc is planning to price its coronavirus vaccine at $50 to $60 per course – higher than other vaccine makers have agreed to charge governments, the Financial Times reported on Tuesday.
The price would apply to the United States and other high-income countries, according to the report. https://on.ft.com/334eV4g
Moderna was not immediately available for comment.
(Reporting by Vishwadha Chander in Bengaluru; Editing by Maju Samuel)
